![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Reva Medical’s Fantom Encore Receives CE Mark
Reva Medical’s Fantom Encore Receives CE Mark
![Grey Approved Stamp](https://www.fdanews.com/ext/resources/test/Drug-Images4/Grey_Approved_Stamp.gif?t=1576541258&width=430)
June 19, 2018
Reva Medical received CE Mark approval for its Fantom Encore product line, a coronary bioresorbable scaffold.
The Encore’s strut profile is thinner than the Fantom, improving outcomes and ease-of-use without compromising strength or x-ray visibility.
The approval covers the Fantom Encore in 3.0 and 3.5 mm diameters, expanding approval past Reva’s second generation product line, Fantom, which had a 2.5 mm scaffold.
Upcoming Events
-
21Oct